EXULT Trademark
Trademark Overview
On Wednesday, December 18, 2024, a trademark application was filed for EXULT with the United States Patent and Trademark Office. The USPTO has given the EXULT trademark a serial number of 98910094. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, September 16, 2025. This trademark is owned by ViiV Healthcare UK (No.3) Limited. The EXULT trademark is filed in the Pharmaceutical Products category with the following description:
Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders
General Information
| Serial Number | 98910094 |
| Word Mark | EXULT |
| Filing Date | Wednesday, December 18, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, September 16, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, October 7, 2025 |
Trademark Statements
| Goods and Services | Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, December 18, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ViiV Healthcare UK (No.3) Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Stevenage SG12NY
GB |
Trademark Events
| Event Date | Event Description |
| Wednesday, December 18, 2024 | NEW APPLICATION ENTERED |
| Wednesday, December 18, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 13, 2025 | ASSIGNED TO EXAMINER |
| Tuesday, January 14, 2025 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Tuesday, January 14, 2025 | LETTER OF SUSPENSION E-MAILED |
| Tuesday, July 15, 2025 | SUSPENSION CHECKED - TO ATTORNEY FOR ACTION |
| Tuesday, January 14, 2025 | SUSPENSION LETTER WRITTEN |
| Wednesday, September 3, 2025 | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED |
| Thursday, September 4, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 4, 2025 | ASSIGNED TO LIE |
| Thursday, September 4, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 1, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
